IQVIA (NYSE:IQV) is a leading global provider of information, innovative technology solutions and contract research services dedicated to using analytics and science to help healthcare stakeholders find better solutions for their patients. Solutions are powered by the IQVIA CORE™, which combines big data, advanced technology, analytics and extensive industry knowledge. Formed through the merger of IMS Health and Quintiles, IQVIA has approximately 55,000 employees worldwide. Learn more at iqvia.com.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
For more information, visit www.amgen.com and www.amgen.gr
GENESIS Pharma was among the first pharmaceutical companies in Europe specialized in biopharmaceutical products and is currently the largest among Greek companies specializing in innovative medicines.
Through long standing strategic alliances with some of the leading multinational pharmaceutical companies committed to cutting edge R&D, GENESIS Pharma has created a strong product portfolio that includes high-tech pharmaceutical products for severe and rare diseases, such as multiple sclerosis, multiple myeloma, leukemia, metastatic pancreatic cancer, metastatic breast cancer etc. Its portfolio also includes products in the therapeutic areas of dermatology, rheumatology and nephrology. For further information please visit www.genesispharma.com.
Sponsorships & Registrations
Dionysia Volika, tel: +30 210 6617 777 (ext. 148), fax: +30 210 6617 778, email: [email protected]
Chrysoula Kordouli, tel: +30 210 6617 777 (ext. 266), fax: +30 210 6617 778, email: [email protected]
Content
Nelly Kapsi, tel: +30 210 6617 777 (ext. 281), +30 6977731311, e-mail: [email protected]
Natalia Toubanaki, tel: +30 210 6617 777 (ext. 281), mob: +30 6947936708, e-mail: [email protected]
338. Kleisthenous Str. 15344, Gerakas, Attiki, Greece
+30 210 6617777
+30 210 6617778
www.boussias.com